SCHEDULE: Janus Henderson Boosts IDEAYA BIOSCIENCES Stake

Sentiment:

Beneficial Ownership Report


Janus Henderson Group plc has increased its beneficial ownership in IDEAYA BIOSCIENCES, INC. to 6.9% of common stock, totaling 6,206,238 shares.

Summary

  • Janus Henderson Group plc filed an Amendment No. 4 to Schedule 13G regarding its beneficial ownership in IDEAYA BIOSCIENCES, INC.
  • The filing indicates Janus Henderson Group plc beneficially owns 6,206,238 shares of IDEAYA BIOSCIENCES, INC. Common Stock.
  • This ownership represents 6.9% of the class of securities.
  • Janus Henderson Group plc holds shared voting power and shared dispositive power over all 6,206,238 shares.
  • The reporting person is classified as an Investment Adviser (IA) and a Parent Holding Company (HC).
  • Indirect subsidiaries JHIUS, JHIUKL, and JHIAIFML are registered investment advisers furnishing investment advice to Managed Portfolios.

Sentiment

Score: 5

Explanation: This is a factual ownership disclosure filing (Schedule 13G Amendment 4) and does not contain information that would typically indicate positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future outlook.

Industry Context

This filing reflects an institutional investor's continued or increased stake in a biotechnology company, a common occurrence in the investment landscape as funds adjust their portfolios based on market conditions and company performance. It does not provide broader industry trend analysis.

Stakeholder Impact

  • Shareholders: Disclosure of a significant institutional investor's stake, providing transparency on major ownership positions.

Key Dates

DateDescription
2022-12-09Date of Power of Attorney execution by Janus Henderson Group plc.
2025-06-30Date of event which requires filing of this statement.
2025-08-14Date of filing of this statement.

Keywords

IDEAYA BIOSCIENCES, Janus Henderson, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Institutional Investor

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.